RNfinity
Research Infinity Logo, Orange eye of horus, white eye of Ra
  • Home
  • Submit
    Research Articles
    Ebooks
  • Articles
    Academic
    Ebooks
  • Info
    Home
    Subject
    Submit
    About
    News
    Submission Guide
    Contact Us
  • Login/sign up
    Login
    Register

Biomedical

Cardiology on the cutting edge: updates from the European Society of Cardiology (ESC) Congress 2020

rnfinity

info@rnfinity.com

orcid logo

Enrique Gallego-Colon,

Enrique Gallego-Colon


Aldo Bonaventura,

Aldo Bonaventura


Alessandra Vecchié,

Alessandra Vecchié


Antonio Cannatà,

Antonio Cannatà


Ciarán Martin Fitzpatrick

Ciarán Martin Fitzpatrick


  Peer Reviewed

copyright icon

© attribution CC-BY

  • 0

rating
440 Views

Added on

2024-12-03

Doi: https://doi.org/10.1186/s12872-020-01734-4

Related Subjects
Anatomy
Biochemistry
Epidemiology
Genetics
Neuroscience
Psychology
Oncology
Medicine
Musculoskeletal science
Pediatrics
Pathology
Pharmacology
Physiology
Psychiatry
Primary care
Women and reproductive health

Abstract

Abstract

The 2020 annual Congress of the European Society of Cardiology (ESC) was the first ever to be held virtually. Under the spotlight of ‘the cutting edge of cardiology’, exciting and ground‑breaking cardiovascular (CV) science was presented both in basic and clinical research. This commentary summarizes essential updates from ESC 2020—The Digital Experience. Despite the challenges that coronavirus disease 2019 (COVID‑19) has posed on the conduct of clinical trials, the ESC Congress launched the results of major studies bringing innovation to the field of general cardiology, cardiac surgery, heart failure, interventional cardiology, and atrial fibrillation. In addition to three new ESC guidelines updates, the first ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Dis ease were presented. As former ESC president, Professor Casadei undoubtedly pointed out the ESC Congress 2020 was a great success. During the ESC 2020 Congress, BMC Cardiovascular Disorders updated to seven journal sections including Arrhythmias and Electrophysiology, CV Surgery, Coronary Artery Disease, Epidemiology and Digital health, Hypertension and Vascular biology, Primary prevention and CV Risk, and Structural Diseases, Heart Failure, and Con genital Disorders. To conclude, an important take‑home message for all CV health care professionals engaged in the COVID‑19 pandemic is that we must foresee and be prepared to tackle the dramatic, long‑term CV complications of COVID‑19 patients.

Key Questions

What were the main topics at ESC Congress 2020?

ESC Congress 2020 covered general cardiology, cardiac surgery, heart failure, interventional cardiology, and atrial fibrillation. The congress presented breakthrough studies and new guidelines in these areas.

How did COVID-19 affect the ESC Congress 2020?

ESC Congress 2020 was held virtually for the first time due to the COVID-19 pandemic. Despite this change, the congress attracted 116,000 delegates from 211 countries and presented cutting-edge cardiovascular science.

What new ESC guidelines were presented in 2020?

ESC presented new guidelines on atrial fibrillation, acute coronary syndromes without persistent ST-segment elevation, adult congenital heart diseases, and sports cardiology for patients with cardiovascular disease.

What was the EMPEROR-Reduced trial about?

The EMPEROR-Reduced trial showed that empagliflozin, an antidiabetic drug, reduced cardiovascular death and hospitalization in patients with heart failure and reduced ejection fraction when added to standard therapy.

What did the EXPLORER-HCM trial reveal?

The EXPLORER-HCM trial found that mavacamten, a new drug, improved exercise capacity, heart function, and symptoms in patients with obstructive hypertrophic cardiomyopathy.

How has BMC Cardiovascular Disorders changed?

BMC Cardiovascular Disorders updated to seven journal sections, including Arrhythmias and Electrophysiology, CV Surgery, Coronary Artery Disease, Epidemiology and Digital Health, Hypertension and Vascular Biology, Primary Prevention and CV Risk, and Structural Diseases, Heart Failure, and Congenital Disorders.

Summary Video Not Available

Review 0

Login

ARTICLE USAGE


Article usage: Dec-2024 to May-2025
Show by month Manuscript Video Summary
2025 May 111 111
2025 April 61 61
2025 March 72 72
2025 February 56 56
2025 January 61 61
2024 December 79 79
Total 440 440
Show by month Manuscript Video Summary
2025 May 111 111
2025 April 61 61
2025 March 72 72
2025 February 56 56
2025 January 61 61
2024 December 79 79
Total 440 440
Related Subjects
Anatomy
Biochemistry
Epidemiology
Genetics
Neuroscience
Psychology
Oncology
Medicine
Musculoskeletal science
Pediatrics
Pathology
Pharmacology
Physiology
Psychiatry
Primary care
Women and reproductive health
copyright icon

© attribution CC-BY

  • 0

rating
440 Views

Added on

2024-12-03

Doi: https://doi.org/10.1186/s12872-020-01734-4

Related Subjects
Anatomy
Biochemistry
Epidemiology
Genetics
Neuroscience
Psychology
Oncology
Medicine
Musculoskeletal science
Pediatrics
Pathology
Pharmacology
Physiology
Psychiatry
Primary care
Women and reproductive health

Follow Us

  • Xicon
  • Contact Us
  • Privacy Policy
  • Terms and Conditions

5 Braemore Court, London EN4 0AE, Telephone +442082758777

© Copyright 2025 All Rights Reserved.